1-10 of 10
Monika Brüggemann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The CD19 Antibody MOR208 Efficiently Triggers Natural Killer Cell-Mediated Cytotoxicity Against Acute Lymphoblastic Leukemia Cells From Pediatric and Adult Patients

Christian Kellner, Eugene A Zhukovsky, Monika Brüggemann, Michael Kneba, MD, PhD, André Schrauder, Martin Schrappe, Roland Repp, Andreas Humpe, Martin Gramatzki, Matthias Peipp
Journal: Blood
Blood (2012) 120 (21): 1502.
https://doi.org/10.1182/blood.V120.21.1502.1502
Published: 2012
Journal Articles

Standardized MRD Flow and ASO IGH RQ-PCR for MRD Quantification in CLL Patients after Rituximab-Containing Immunochemotherapy – a Comparative Analysis in 574 Samples from the Randomized GCLLSG CLL8 Trial

Sebastian Boettcher, MD, Stephan Stilgenbauer, MD, PhD, Raymonde Busch, Monika Brüggemann, MD, PhD, Thorsten Raff, MD, Kirsten Fischer, MD, Günter Fingerle-Rowson, MD, PhD, Anna-Maria Fink, MD, Christiane Pott, MD, Hartmut Döhner, MD, PhD, Michael Hallek, MD, PhD, Michael Kneba, MD, PhD, Matthias Ritgen, MD, on Behalf Of GCLLSG
Journal: Blood
Blood (2008) 112 (11): 3139.
https://doi.org/10.1182/blood.V112.11.3139.3139
Published: 2008
Journal Articles

MRD Kinetics in Adult Transplantation Recipients with Relapsed Acute Lymphoblastic Leukemia Depend on Initial Molecular Response to Front-Line Chemotherapy.

Monika Brüggemann, MD, Thorsten Raff, MD, Christiane Pott, MD, Sebastian Böttcher, MD, Matthias Ritgen, MD, Renate Arnold, MD, Dieter Hoelzer, MD, Nicola Goekbuget, MD, Michael Kneba, MD
Journal: Blood
Blood (2007) 110 (11): 2799.
https://doi.org/10.1182/blood.V110.11.2799.2799
Published: 2007
Journal Articles

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Takashi Akasaka, Theodore Balasas, Lisa J. Russell, Kei-ji Sugimoto, Aneela Majid, Renata Walewska, E. Loraine Karran, David G. Brown, Kelvin Cain, Lana Harder, Stefan Gesk, Jose Ignacio Martin-Subero, Mark G. Atherton, Monika Brüggemann, María José Calasanz, Teresa Davies, Oskar A. Haas, Anne Hagemeijer, Helena Kempski, Michel Lessard, Debra M. Lillington, Sarah Moore, Florence Nguyen-Khac, Isabelle Radford-Weiss, Claudia Schoch, Stéphanie Struski, Polly Talley, Melanie J. Welham, Helen Worley, Jon C. Strefford, Christine J. Harrison, Reiner Siebert, Martin J. S. Dyer
Journal: Blood
Blood (2006) 109 (8): 3451–3461.
https://doi.org/10.1182/blood-2006-08-041012
Published: 2006
Includes: Supplemental data
Journal Articles

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials

Clinical Trials & Observations
Thorsten Raff, Nicola Gökbuget, Silke Lüschen, Regina Reutzel, Matthias Ritgen, Sebastian Irmer, Sebastian Böttcher, Heinz-August Horst, Michael Kneba, Dieter Hoelzer, Monika Brüggemann, for the GMALL Study Group
Journal: Blood
Blood (2006) 109 (3): 910–915.
https://doi.org/10.1182/blood-2006-07-037093
Published: 2006
Journal Articles

Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma

Clinical Trials & Observations
Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff, Monika Brüggemann, Matthias Ritgen, Benedikt Gahn, Michael Unterhalt, Martin Dreyling, Wolfgang Hiddemann, Reiner Siebert, Peter Dreger, Michael Kneba
Journal: Blood
Blood (2006) 107 (6): 2271–2278.
https://doi.org/10.1182/blood-2005-07-2845
Published: 2006
Journal Articles

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

Clinical Trials & Observations
Monika Brüggemann, Thorsten Raff, Thomas Flohr, Nicola Gökbuget, Makoto Nakao, Jo Droese, Silke Lüschen, Christiane Pott, Matthias Ritgen, Urban Scheuring, Heinz-August Horst, Eckhard Thiel, Dieter Hoelzer, Claus R. Bartram, Michael Kneba, for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
Journal: Blood
Blood (2006) 107 (3): 1116–1123.
https://doi.org/10.1182/blood-2005-07-2708
Published: 2006
Journal Articles

Quantitative Assessment of Molecular Remission Following Autologous Stem Cell Transplantation Predicts Long Term Remission in Mantle Cell Lymphoma.

Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff, Monika Brüggemann, Matthias Ritgen, Michael Unterhalt, Martin Dreyling, Wolfgang Hiddemann, Reiner Siebert, Peter Dreger, Michael Kneba
Journal: Blood
Blood (2005) 106 (11): 3275.
https://doi.org/10.1182/blood.V106.11.3275.3275
Published: 2005
Journal Articles

Measurement of Minimal Residual Disease (MRD) after Consolidation Therapy as a Means of Early Detection of Relapse in Adult Acute Lymphoblastic Leukemia (ALL).

Michael Kneba, MD, PhD, Monika Brüggemann, MD, Nicola Gökbuget, MD, Regina Reutzel, Dieter Hoelzer, MD, PhD, Thorsten Raff, MD
Journal: Blood
Blood (2005) 106 (11): 538.
https://doi.org/10.1182/blood.V106.11.538.538
Published: 2005
Journal Articles

Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR

Clinical Trials & Observations Brief Report
Matthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, Andreas Humpe, Monika Brüggemann, Christiane Pott, Thorsten Raff, Alexander Kröber, Donald Bunjes, Richard Schlenk, Norbert Schmitz, Hartmut Döhner, Michael Kneba, Peter Dreger
Journal: Blood
Blood (2004) 104 (8): 2600–2602.
https://doi.org/10.1182/blood-2003-12-4321
Published: 2004